SARS-CoV-2 seroprevalence among healthcare workers from a tertiary care center in Riyadh, Saudi Arabia

References

1. 1.↵
   1. Lai CC,
   2. Shih TP,
   3. Ko WC,
   4. Tang HJ,
   5. Hsueh PR.

   Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55: 105924.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Abbas M,
   2. Robalo Nunes T,
   3. Martischang R,
   4. Zingg W,
   5. Iten A,
   6. Pittet D, et al.

   Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrob Resist Infect Control 2021; 10: 7.

   OpenUrl
3. 3.↵
   1. Shorten RJ,
   2. Haslam S,
   3. Hurley MA,
   4. Rowbottom A,
   5. Myers M,
   6. Wilkinson P, et al.

   Seroprevalence of SARS-CoV-2 infection in healthcare workers in a large teaching hospital in the North West of England: a period prevalence survey. BMJ Open 2021; 11: e045384.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Lai X,
   2. Wang M,
   3. Qin C,
   4. Tan L,
   5. Ran L,
   6. Chen D, et al.

   Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Netw Open 2020; 3: e209666.

   OpenUrl
5. 5.↵
   1. Shields A,
   2. Faustini SE,
   3. Perez-Toledo M,
   4. Jossi S,
   5. Aldera E,
   6. Allen JD, et al.

   SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax 2020; 75: 1089–1094.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Alserehi HA,
   2. Alqunaibet AM,
   3. Al-Tawfiq JA,
   4. Alharbi NK,
   5. Alshukairi AN,
   6. Alanazi KH, et al.

   Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals. Diagn Microbiol Infect Dis 2021; 99: 115273.

   OpenUrl
7. 7.↵
   1. Black JRM,
   2. Bailey C,
   3. Przewrocka J,
   4. Dijkstra KK,
   5. Swanton C.

   COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet 2020; 395: 1418–1420.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Huang AT,
   2. Garcia-Carreras B,
   3. Hitchings MDT,
   4. Yang B,
   5. Katzelnick LC,
   6. Rattigan SM, et al.

   A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun 2020; 11: 4704.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Alharbi NK,
   2. Alghnam S,
   3. Algaissi A,
   4. Albalawi H,
   5. Alenazi MW,
   6. Albargawi AM, et al.

   Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. J Infect Public Health 2021; 14: 832–838.

   OpenUrl
10. 10.↵
    1. Rostami A,
    2. Sepidarkish M,
    3. Leeflang MMG,
    4. Riahi SM,
    5. Nourollahpour Shiadeh M,
    6. Esfandyari S, et al.

    SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect 2021; 27: 331–340.

    OpenUrlPubMed
11. 11.↵
    1. Dorigatti I,
    2. Lavezzo E,
    3. Manuto L,
    4. Ciavarella C,
    5. Pacenti M,
    6. Boldrin C, et al.

    SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’. Nat Commun 2021; 12: 4383.

    OpenUrlCrossRef
12. 12.↵
    1. McDermott A.

    Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon. Proc Natl Acad Sci 2021; 118: e2107692118.

    OpenUrlFREE Full Text
13. 13.↵
    1. Piccoli L,
    2. Ferrari P,
    3. Piumatti G,
    4. Jovic S,
    5. Rodriguez BF,
    6. Mele F, et al.

    Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland. Lancet Reg Heal 2021; 1: 100013.

    OpenUrl
14. 14.↵
    1. Li B,
    2. Yang J,
    3. Zhao F,
    4. Zhi L,
    5. Wang X,
    6. Liu L, et al.

    Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109: 531–538.

    OpenUrlPubMed
15. 15.↵
    SaudiCDC. Coronavirus disease COVID-19 guidelines [Internet]. MOH; 2020. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Coronavirus-Disease-2019-Guidelines-v1.2.pdf